<DOC>
	<DOC>NCT01431599</DOC>
	<brief_summary>The purpose of this study is to evaluate the early clinical outcome of the short-course preoperative chemoradiotherapy, 33Gy/10 fx and delayed operation after chemoradiation, the investigators initiated the clinical trial of KROG 11-02.</brief_summary>
	<brief_title>Short-course Preoperative Chemoradiotherapy for Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>1. histologically confirmed adenocarcinoma 2. distal margin of the tumor located &lt; 8 cm above the anal verge 3. cT34 or cN+ classification as determined by endorectal ultrasonography (EUS) and CT 4. patient older than age 18 years 5. Karnofsky performance score &gt;= 70 1. distant metastasis identified during staging workup 2. previous or concurrent malignancy 3. pregnant or breastfeeding women 4. impending rectal obstruction 5. familial adenomatous polyposis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Locally advanced rectal cancer</keyword>
</DOC>